A decision-analytical model shows that everolimus has a favorable budget impact when introduced into the treatment algorithm for metastatic renal cell carcinoma.
Zhimei Liu, PhD
Advertisement
Articles by Zhimei Liu, PhD
Advertisement
Latest Updated Articles
- Budget Impact of Everolimus in Treating Metastatic Renal Cell Carcinoma
Published: November 13th 2012 | Updated:
Advertisement
Advertisement
